• E-mailMona.S.Nilsen@uib.no
  • Phone+47 917 62 425
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen

Hormone Laboratory Research Group (https://www.uib.no/en/rg/hormonelaboratory)

Obesity. Type 2 diabetes. Adipose tissue. Metabolism.

Involved in teaching of bachelor students in human nutrition

Co-supervising master students

Academic article
  • Show author(s) (2021). Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. Diabetes. 680-695.
  • Show author(s) (2021). Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 10 pages.
  • Show author(s) (2020). 3-hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism. Diabetes. 1903-1916.
Academic lecture
  • Show author(s) (2020). Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.
  • Show author(s) (2019). Circulating 3-hydroxyisobutyrate (3-HIB) as a clinical marker of prediabetes and T2D in patients with obesity.
  • Show author(s) (2019). A novel amino acid transporter modulating insulin resistance via adipocytes ​.
  • Show author(s) (2018). Amino acid metabolism in adipocytes.
  • Show author(s) (2019). Inhibition of serine transporter SLC7A10 promotes lipid accumulation through altered BCAA catabolism in adipocytes​.
  • Show author(s) (2019). Adipocyte amino acid metabolism in obesity-related metabolic diseases .

More information in national current research information system (CRIStin)

PhD project: "Branched-chain amino acid metabolism in obesity and insulin resistance"


Board member in Research School in Clinical Medicine